New injection shows promise for obesity and diabetes
NCT ID NCT04838405
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 33 times
Summary
This early-stage study tested an experimental drug called CT-388 in 129 overweight or obese adults, some with type 2 diabetes. The goal was to check safety and how the drug affects body weight and blood sugar. Participants received either the drug or a placebo as a shot under the skin.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carmot Clinical Research Unit 101
Perth, Western Australia, 6009, Australia
-
Carmot Clinical Research Unit 105
Monterrey, Nuevo León, 66260, Mexico
Conditions
Explore the condition pages connected to this study.